Lataa...
Sequential Therapy with Minocycline and Candesartan Improves Long Term Recovery after Experimental Stroke
BACKGROUND: Minocycline and candesartan have both shown promise as candidate therapeutics in ischemic stroke, with multiple, and somewhat contrasting, molecular mechanisms. Minocycline is an anti-inflammatory, antioxidant and anti-apoptotic agent and a known inhibitor of matrix metalloproteinases (M...
Tallennettuna:
| Julkaisussa: | Transl Stroke Res |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4559761/ https://ncbi.nlm.nih.gov/pubmed/26004281 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12975-015-0408-8 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|